关于gemcitabine的FDA不良事件报告系统 (FAERS) 的现实世界药监测研究
Cheng Zhang1, Ke Li1, Shu-Ning Xu1
1Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Expert opinion on drug safety
|October 23, 2024
概括
这项研究分析了FAERS数据中的gemcitabine不良事件 (AE),确定了常见和意想不到的副作用. 这些发现有助于更好地了解gemcitabine的安全性和临床使用.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 数据挖掘 数据挖掘
背景情况:
- 吉姆西塔是许多癌症的基石化疗剂.
- 了解其不良事件 (AE) 概况对于患者安全至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库为AE监测提供了宝贵的资源.
研究的目的:
- 通过使用FAERS数据,全面评估与gemcitabine相关的不良事件 (AE).
- 为了确定与凝胺治疗相关的常见和潜在的意想不到的副作用.
- 为改善gemcitabine的临床应用和安全提供见解.
主要方法:
- 对2004年1月至2023年6月的FAERS数据进行分析.
- 使用报告赔率比率 (ROR) 和贝叶斯信心传播神经网络 (BCPNN) 算法.
- 确定了具有统计学上显著的gemcitabine积极信号的AE.
主要成果:
- 超过23,000份报告将凝胺确定为首要的疑似药物,导致超过74,000个AE.
- 常见的副作用包括血小板缺血,发烧症,中性质缺血和贫血.
- 此外,还发现了一些意想不到的副作用,如腹部疼痛,腹腔溢出,,胃肠道出血等. "血液和淋巴系统疾病"是最重要的系统器官类 (SOC).
- 平均AE发病时间为24天,大多数发生在治疗开始后的30天内.
结论:
- 吉姆西塔与影响多个器官系统的各种不良事件有关.
- 该研究确定了预期和意想不到的副作用,包括显著的住院病例.
- 这些发现可以为临床实践提供信息,并增强在癌症治疗中安全使用凝丁的可能性.
相关概念视频
01:19Pharmacovigilance
778
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
778
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:11Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147